This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Silexion Therapeutics to attend BIO...
Business conference attendance

Silexion Therapeutics to attend BIO Convention

Analysis based on 6 articles · First reported Jun 16, 2026 · Last updated Jun 16, 2026

Sentiment
20
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement of Silexion Therapeutics' attendance at the Cape Town International Convention Centre could positively impact investor perception of the company, potentially leading to increased interest and future investment in its RNAi therapies. This event provides a platform for Silexion Therapeutics to engage with potential partners and investors, which could accelerate the development and commercialization of its lead product candidate, SIL204.

Biotechnology Pharmaceuticals
Event Summary

Silexion Therapeutics, a clinical-stage biotechnology company focused on RNA interference (RNAi) therapies for KRAS-driven cancers, announced that its management, including CEO Ilan Hadar and CFO Mirit Horenshtein-Hadar, will attend the 2026 Cape Town International Convention Centre in San Diego, CA, from June 22-25. During the convention, Silexion Therapeutics will host one-on-one meetings to discuss its innovative treatments, including its lead second-generation product candidate, SIL204, which is advancing towards clinical trials in Israel and the European Union. The company aims to push therapeutic advancements in oncology, particularly for locally advanced pancreatic cancer.

Entities Involved
priv
Silexion Therapeutics
Silexion Therapeutics is attending the 2026 Cape Town International Convention Centre to host one-on-one meetings, which could lead to new partnerships or investments, positively impacting its market position and funding for its RNAi therapies.
Importance 100.0 Sentiment 20.0
per
Ilan Hadar
Ilan Hadar, as CEO of Silexion Therapeutics, will represent the company at the Cape Town International Convention Centre, engaging in meetings that could influence the company's future.
Importance 70.0 Sentiment 10.0
per
Mirit Horenshtein-Hadar
Mirit Horenshtein-Hadar, CFO of Silexion Therapeutics, will attend the Cape Town International Convention Centre to participate in one-on-one meetings, which are crucial for the company's financial and strategic development.
Importance 70.0 Sentiment 10.0
priv
LifeSci Advisors
LifeSci Advisors is mentioned as an investor relations contact for Silexion Therapeutics, assisting in investor outreach and engagement.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.